Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Before investing your money, it's essential to understand key factors. Get informed to make the best investment decisions.
21,805 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Pi Network’s PI tumbles to a fresh all-time low as a 130 million token unlock looms, signaling potential further down...
Trump unveils a plan to monetize passage through the Strait of Hormuz, triggering market moves and raising questions ...
A cooler June CPI prints suggest inflation is cooling, potentially giving the Fed room to hold rates steady. Markets ...
An academic paper analyzes UWM's 2021 broker ultimatum tied price and finds rivals shaved an average of 5 basis point...
As Boyd Gaming nears its July 23 earnings, traders are weighing a potential 17.2% upside fueled by a disciplined buyb...
Coinbase CEO Brian Armstrong sparks a polarized debate by asking if Bitcoin's bottom is in, triggering thousands of v...
CHLA pushes for an FHA pilot that would pay lenders directly for sub-$100K mortgages, arguing the move is needed to u...
As lawmakers race toward two July floor windows, the CLARITY Act stands as the key to how digital assets are classifi...
Circle won a federal trust charter, reframing its role in the financial system. Banks warn that stablecoins may sipho...
XRP starts the week trading around $1.52 as it tests critical levels near $1.60 and $1.40, with volatility mounting a...
Weekly jobless claims dropped to the year's low, a sign that the labor market may be stabilizing even as some sectors...